CIENCIAS DE LA SALUD
Department
Francisco
Abad Santos
Publications by the researcher in collaboration with Francisco Abad Santos (48)
2024
-
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain
Clinical and Translational Science, Vol. 17, Núm. 1
2023
-
'Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation' by Ali et al. - reassess the evidence, shall we?
Pharmacogenetics and genomics, Vol. 33, Núm. 4, pp. 88-89
-
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers
Journal of Personalized Medicine, Vol. 13, Núm. 3
-
“Pharmacogenetics of siponimod: A systematic review” by Díaz-Villamarín et al. – Information is power
Biomedicine and Pharmacotherapy
2022
-
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494
-
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives
Pharmaceutics, Vol. 14, Núm. 3
2021
-
Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
Frontiers in Pharmacology, Vol. 12
-
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling
Clinical Pharmacokinetics, Vol. 60, Núm. 2, pp. 261-270
-
HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B∗ 57:01 genotyping to predict abacavir hypersensitivity reaction in Spain
Pharmacogenetics and Genomics, Vol. 31, Núm. 3, pp. 53-59
-
High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects
Frontiers in Pharmacology, Vol. 12
-
Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers
Biomedicine and Pharmacotherapy, Vol. 133
-
Influence of Genetic Polymorphisms on the Response to Tramadol, Ibuprofen, and the Combination in Patients With Moderate to Severe Pain After Dental Surgery
Clinical Therapeutics, Vol. 43, Núm. 5, pp. e86-e102
-
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics
Advances in Therapy, Vol. 38, Núm. 2, pp. 1035-1054
-
PriME-PGX: La Princesa university hospital multidisciplinary initiative for the implementation of pharmacogenetics
Journal of Clinical Medicine, Vol. 10, Núm. 17
-
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial
Human Psychopharmacology, Vol. 36, Núm. 1, pp. 1-12
2020
-
Author’s Response to: ‘Letter to the Editor in Response to: “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”’
Advances in Therapy
-
Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects
Clinical Drug Investigation, Vol. 40, Núm. 7, pp. 617-628
-
Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran
Advances in Therapy, Vol. 37, Núm. 8, pp. 3537-3550
-
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
BMC Pharmacology and Toxicology, Vol. 21, Núm. 1
-
Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates
Biomedicines, Vol. 8, Núm. 4